V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10477509 | 10063479 | 1.81 | 45.8 | null | 2020-09-02 | 2020-09-12 | Venetoclax | 02 | null | VENETOCLAX | 100337938 |
| 10477780 | 10063480 | 1.75 | 0 | Adjuvant (A) | 2019-03-19 | 2019-03-19 | Venetoclax | 02 | N | VENETOCLAX | 101618022 |
| 10477816 | 10063481 | 1.55 | 61.8 | null | 2019-10-07 | 2019-10-10 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 101517767 |
| 10477867 | 10063482 | 1.49 | 84 | null | 2018-06-21 | 2018-07-01 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 101346161 |
| 10477940 | 10063483 | 1.69 | 81.8 | 03 | 2017-05-11 | 2017-05-27 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 101656990 |
| 10477969 | 10063484 | 1.8 | 77 | Palliative (P) | 2016-12-06 | 2017-10-31 | BENDAMUSTINE + RITUXIMAB | 02 | N | BENDAMUSTINE + RITUXIMAB | 100782003 |
| 10477990 | 10063485 | 1.49 | 68.7 | Adjuvant (A) | null | 2018-01-31 | Avelumab | 02 | N | NIVOLUMAB | 100880198 |
| 10477995 | 10063486 | 1.5 | 101 | null | null | 2022-05-13 | Avelumab | null | null | NIVOLUMAB | 100905555 |
| 10478018 | 10063487 | 1.51 | 86.8 | 03 | null | 2020-05-02 | Avelumab | 02 | N | VENETOCLAX | 101065849 |
| 10478028 | 10063488 | 1.85 | 88.1 | null | null | 2020-02-15 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 100334345 |
| 10478099 | 10063489 | 1.68 | 67.3 | null | null | 2019-08-02 | Venetoclax | 02 | null | VENETOCLAX | 101248703 |
| 10478206 | 10063490 | 1.69 | 72.8 | null | 2022-03-06 | 2022-04-07 | Capecitabine + Oxaliplatin 21day | N | null | CAPECITABINE + OXALIPLATIN | 101269681 |
| 10478223 | 10063491 | 1.86 | 110 | Neo-adjuvant (N) | 2019-06-27 | 2019-07-05 | Avelumab | 01 | N | CARBOPLATIN + GEMCITABINE | 100055196 |
| 10478241 | 10063492 | 1.73 | 61.5 | Palliative (P) | 2020-12-24 | 2021-01-27 | Avelumab | 02 | N | AVELUMAB | 100094916 |
| 10478244 | 10063493 | 1.75 | 68.2 | null | 2020-03-03 | 2020-03-15 | RUXOLITINIB | null | null | RUXOLITINIB | 101562540 |
| 10478268 | 10063494 | 1.74 | 73.7 | Disease modification (D) | 2019-08-23 | 2019-08-23 | Avelumab | N | N | BENDAMUSTINE + RITUXIMAB | 101682411 |
| 10478353 | 10063496 | 1.46 | 51 | null | 2021-06-12 | 2021-11-28 | Avelumab | 02 | null | BENDAMUSTINE + RITUXIMAB | 100837732 |
| 10478471 | 10063497 | 1.5 | 78.8 | null | 2022-04-20 | 2022-05-20 | RUXOLITINIB | 02 | null | RUXOLITINIB | 101628324 |
| 10478526 | 10063498 | null | 69 | Palliative (P) | 2020-07-18 | 2020-08-05 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 101715442 |
| 10478666 | 10063499 | 1.67 | 72 | 03 | 2020-01-30 | 2020-02-22 | CEMIPLIMAB | N | N | CEMIPLIMAB | 100445526 |
| 10478827 | 10063500 | 1.62 | 93.9 | Curative (C) | null | 2016-12-10 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101557125 |
| 10478838 | 10063501 | 1.74 | 66 | null | null | 2022-05-28 | Avelumab | 02 | null | CAPECITABINE + OXALIPLATIN | 100148991 |
| 10478886 | 10063502 | 1.63 | 68 | Palliative (P) | 2017-07-08 | 2017-08-12 | Avelumab | N | N | NIVOLUMAB | 100964971 |
| 10478991 | 10063503 | 1.55 | 45.8 | Palliative (P) | 2015-08-28 | 2020-01-29 | Avelumab | 02 | N | FLUOROURACIL + OXALIPLATIN | 100486701 |
| 10479133 | 10063504 | 1.79 | 63 | 03 | 2020-04-14 | 2020-05-12 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101522080 |
| 10479227 | 10063505 | 1.7 | 80 | 03 | 2019-12-22 | 2019-12-22 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100921521 |
| 10479247 | 10063506 | 1.82 | 98 | Palliative (P) | null | 2022-04-21 | Avelumab | 02 | N | FLUOROURACIL + OXALIPLATIN | 101116360 |
| 10479274 | 10063507 | 1.84 | 75.8 | Palliative (P) | 2020-03-22 | 2020-06-23 | Avelumab | 02 | N | DARATUMUMAB | 101274669 |
| 10479358 | 10063508 | 1.63 | 74.6 | Adjuvant (A) | 2017-10-18 | 2017-11-08 | Venetoclax | 02 | N | VENETOCLAX | 100276862 |
| 10479374 | 10063509 | 1.62 | null | null | 2022-05-10 | 2022-05-15 | Avelumab | 99 | null | RUXOLITINIB | 100813712 |
| 10479391 | 10063510 | 1.49 | 86.3 | null | 2018-06-05 | 2018-06-11 | Irinotecan + Modified De Gramont | 01 | null | FLUOROURACIL + IRINOTECAN | 101681733 |
| 10479402 | 10063512 | 1.56 | 69.1 | Palliative (P) | 2022-03-29 | 2022-04-20 | RUXOLITINIB | 02 | N | RUXOLITINIB | 100035866 |
| 10479543 | 10063513 | 1.67 | 75 | null | 2019-01-05 | 2019-01-14 | RUXOLITINIB | N | null | AVELUMAB | 100512914 |
| 10479706 | 10063515 | 1.73 | 56.1 | 03 | 2018-01-26 | 2018-02-04 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 100036254 |
| 10479756 | 10063516 | 1.77 | 63.8 | null | 2019-09-06 | 2020-03-15 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100059656 |
| 10479792 | 10063517 | 1.52 | 80.8 | Adjuvant (A) | 2021-04-06 | 2021-04-28 | Avelumab | 02 | N | TRASTUZUMAB | 100215686 |
| 10479793 | 10063518 | 1.76 | 63.7 | null | 2017-11-21 | 2018-02-26 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100606778 |
| 10479827 | 10063519 | 1.75 | 79.1 | Adjuvant (A) | 2019-10-23 | 2021-11-15 | Avelumab | 02 | N | FLUOROURACIL + IRINOTECAN | 101459334 |
| 10479851 | 10063520 | null | 70.5 | null | 2021-08-25 | 2021-09-22 | Avelumab | 02 | N | FLUOROURACIL + IRINOTECAN | 101838333 |
| 10479860 | 10063521 | 1.69 | 96.65 | Palliative (P) | 2017-10-13 | 2017-11-28 | DARATUMUMAB | 02 | N | DARATUMUMAB | 101339784 |
| 10479988 | 10063522 | 1.71 | 58.6 | Palliative (P) | 2016-03-11 | 2019-02-12 | Avelumab | 02 | N | AVELUMAB | 100487879 |
| 10480051 | 10063523 | 1.6 | 66.8 | Palliative (P) | null | 2016-09-08 | CAPECITABINE + OXALIPLATIN | null | N | CAPECITABINE + OXALIPLATIN | 101520253 |
| 10480092 | 10063524 | null | 64 | Palliative (P) | 2017-01-24 | 2017-02-04 | Venetoclax | 02 | null | VENETOCLAX | 101768505 |
| 10480208 | 10063525 | 1.59 | 77 | null | 2022-03-30 | 2022-03-30 | DARATUMUMAB | 02 | null | DARATUMUMAB | 100621620 |
| 10480215 | 10063526 | 1.68 | 79 | Palliative (P) | 2020-05-18 | 2020-05-18 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 100454175 |
| 10480246 | 10063527 | 1.77 | 87.4 | null | 2021-04-11 | 2021-04-13 | Avelumab | 02 | null | AVELUMAB | 101323307 |
| 10480357 | 10063528 | 1.63 | 69.7 | Palliative (P) | 2016-03-25 | 2019-11-09 | Venetoclax | 01 | null | VENETOCLAX | 101619979 |
| 10480360 | 10063529 | 1.56 | 61.6 | null | 2019-10-30 | 2019-10-30 | DARATUMUMAB | 02 | null | DARATUMUMAB | 100916815 |
| 10480381 | 10063530 | 1.54 | 60 | 02 | 2020-09-14 | 2020-10-05 | Avelumab | 02 | null | FLUOROURACIL + IRINOTECAN | 100301996 |
| 10480401 | 10063531 | 1.68 | 79.5 | Curative (C) | 2020-10-08 | 2020-11-12 | RUXOLITINIB | 02 | N | RUXOLITINIB | 101741382 |